Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

LCTX Stock Forecast, Price Targets, Chart, Dividends & Analysis

Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

Sector: Manufacturing   

Industry: Biological Product (except Diagnostic) Manufacturing

0.84
 
USD
  
0.01
  
(0.70%)
Previous close: 0.8386  Open: 0.8307  Bid: 0.832  Ask: 0.855
52 week range    
0.77   
   1.61
Mkt Cap: 166 M  Avg Vol (90 Days): 428,794
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Wednesday 6th November 2024

Stock Rankings

15
Technical
21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

LCTX Income Statement

Annual
Dec-13Dec-14Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends-87000.0
Amortization of intangibles-3 M-7 M-4 M-2 M-2 M-2 M47 M47 M47 M47 M
Basic EPS from continuing operations-0.14-0.26-0.15-0.12
Basic EPS total-0.490.35-0.58-0.36-0.03-0.14-0.26-0.15-0.12
Basic weighted shares outstanding54 M66 M97 M114 M126903.0145533.0150044.0164502.0170 M173 M
Cost of sales-792659.0-837000.0-358000.0-168000.0-302000.0-412000.0385000.01 M728000.0671000.0
Depreciation-656759.0-1 M-1 M-947000.0-1 M-1 M823000.0663000.0582000.0562000.0
Depreciation unreconciled-1 M
DepreciationAndAmortization-656759.0-1 M-1 M-947000.0-1 M-1 M823000.0663000.0582000.0562000.0
Diluted EPS total-0.81-0.550.34-0.17-0.36-0.08-0.14-0.26-0.15-0.12
Diluted normalized net income/share-0.12
Diluted weighted shares outstanding54 M66 M100 M221 M93 M523 M150044.0164502.0170 M173 M
Earnings from equity interest-5 M3 M9 M
EarningsFromEquityInterestNetOfTax-5 M3 M9 M
GainOnSaleOfPPE5120.0-8926.02 M109000.09000.05000.0
GainOnSaleOfSecurity3000.0-2013.0-395000.0521000.01 M-3 M5 M6 M-2 M-176000.0
GeneralAndAdministrativeExpense16 M18 M28 M20 M25 M24 M16 M18 M23 M17 M
Gross operating profit4 M4 M6 M3 M5 M3 M388000.02 M14 M8 M
Income before tax-56 M-51 M19 M-23 M-47 M-19 M-22 M-43 M-26 M-23 M
Income restructuring and M&A26 M-700000.0700000.0
Income taxes-3 M-7 M346000.0-7 M-1 M541000.0-2 M
Interest income-747000.0-692000.075 M11 M1 M829000.02 M
InterestExpenseNonOperating-1 M-2000.0-829000.0
MarketingExpense385000.0
MinorityInterests9 M7 M15 M3 M794000.0118000.036000.0251000.080000.0-7000.0
MiscOtherSpecialCharges-209177.0-384000.0-403000.02 M3 M6 M3 M2 M-2 M-2000.0
Net income from total operations-44 M-36 M-50 M-38 M34 M-12 M-21 M-43 M-26 M-21 M
NetIncomeCommonStockholders-44 M-36 M-50 M-38 M34 M-12 M-21 M-43 M-26 M-21 M
NetIncomeContinuousOperations-44 M-36 M-50 M-38 M34 M-12 M-21 M-43 M-26 M-21 M
NetNonOperatingInterestIncomeExpense-747000.0-692000.075 M11 M1 M2000.0829000.02 M
NetOperatingInterestIncomeExpense-578.0-89000.0
NonRecurringOperationExpense1 M4 M
Normalized income-33 M-24 M
Operating income-56 M-51 M-59 M-44 M-47 M-42 M-26 M-49 M-23 M-25 M
Operating income before depreciation (EBITDA)-53 M-42 M24 M-19 M-44 M-16 M-24 M-48 M-22 M-24 M
OperatingExpense-60 M-55 M-65 M-44 M-46 M-42 M28 M52 M36 M33 M
Other income net204057.0384000.05 M-4 M-4 M-12 M-3 M-6 M4 M178000.0
Other special charges385000.0
OtherGandA16 M18 M28 M20 M25 M24 M16 M18 M23 M17 M
OtherImpairmentOfCapitalAssets-3 M
OtherOperatingExpenses17 M-55 M-65 M-44 M800000.0-42 M28 M52 M36 M-354000.0
OtherunderPreferredStockDividend-87000.0
PreferredStockDividends-87000.0
RentAndLandingFees16 M18 M28 M20 M25 M24 M
Research & development expense27 M38 M36 M24 M21 M18 M12 M34 M14 M16 M
ResearchExpense27 M38 M36 M24 M21 M18 M12 M34 M14 M16 M
RestructringAndMnAIncome26 M-700000.0700000.0
Revenue per share-2 M-7 M-4 M-2 M-2 M-2 M47 M47 M47 M47 M
SalariesAndWages-3 M-4 M-8 M-4 M-298 M-4 M2 M4 M4 M
Selling Gen & administrative expense16 M18 M28 M20 M25 M24 M16 M18 M23 M17 M
SellingAndMarketingExpense385000.0
Special income/charges-26 M700000.0-385000.0-1 M-728000.0-671000.0
Total Income available for interest expense (EBIT)-56 M-51 M19 M-23 M-47 M-19 M-26 M-49 M-23 M-25 M
Total common shares outstanding70 M83 M111 M127 M149 M150 M162 M170 M170 M189 M
Total net income-44 M-36 M-50 M-38 M34 M-12 M-21 M-43 M-26 M-21 M
Total ordinary shares189 M189 M189 M189 M189 M189 M189 M189 M189 M189 M
Total revenues4 M5 M6 M3 M5 M4 M2 M4 M15 M9 M
TotalExpenses-60 M-56 M-65 M-44 M-47 M-42 M28 M54 M37 M34 M
TotalRevenue276058.0376000.0736000.03 M5 M4 M773000.04 M15 M9 M
WriteDown671000.0
WriteOff728000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University